Please provide your email address to receive an email when new articles are posted on . The GATHER2 phase 3 clinical trial of Zimura for the treatment of geographic atrophy met its primary endpoint ...
This study indicated that by analyzing the data of one of the most extensive GA patient cohorts in the Nordic countries, it established a data set on the long-term treatment-naive GA growth dynamics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback